TISSIUM
Develops nerve-repair and tissue-healing polymer technologies intended to improve surgical procedures and outcomes in operating rooms.
Overview
Tissium develops polymer-based medical technology for nerve healing, with a focus on products designed for use in surgical settings. Its current push targets adoption in the US operating room, positioning the company in advanced materials and medtech rather than AI software. The company raised $60 million in an undisclosed round dated June 24, 2026. The financing is intended to support its move into the US market, where its differentiator is a PhD-originated polymer approach to repairing nerves and improving surgical treatment options.
Funding History
A PhD student’s nerve-healing polymer just raised €60M to take on the US operating room
Frequently Asked Questions
- How much has TISSIUM raised in total?
- TISSIUM has raised a total of $60M across 1 funding round.
- Who are TISSIUM's investors?
- TISSIUM's investors include Undisclosed.
- What does TISSIUM do?
- Tissium develops polymer-based medical technology for nerve healing, with a focus on products designed for use in surgical settings. Its current push targets adoption in the US operating room, positioning the company in advanced materials and medtech rather than AI software. The company raised $60 million in an undisclosed round dated June 24, 2026. The financing is intended to support its move into the US market, where its differentiator is a PhD-originated polymer approach to repairing nerves and improving surgical treatment options.
- Where is TISSIUM headquartered?
- TISSIUM is headquartered in Paris, France.
Investors
Related Insights
A comprehensive analysis of Isembard's funding history, investors, competitive position, and growth trajectory in the Deep Tech space.
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Every AI funding round in June 2026—from Lovable's $12B raise to top fintech, infrastructure & enterprise deals. Updated daily with VCs, valuations & trends.